|
Volumn 357, Issue 22, 2007, Pages 2306-2307
|
Progesterone and preterm birth [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HORMONE;
HYDROXYPROGESTERONE ACETATE;
PLACEBO;
PROGESTERONE;
17-ALPHA-HYDROXY-PROGESTERONE CAPROATE;
HYDROXYPROGESTERONE CAPROATE;
PROGESTERONE DERIVATIVE;
UNCLASSIFIED DRUG;
BIRTH WEIGHT;
CHILDBIRTH;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
DISEASE PREDISPOSITION;
DRUG EFFICACY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GESTATION PERIOD;
HUMAN;
LETTER;
PREGNANCY;
PREMATURITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SPONTANEOUS ABORTION;
VAGINAL DELIVERY;
ECHOGRAPHY;
FEMALE;
GESTATIONAL AGE;
HISTOLOGY;
METHODOLOGY;
MULTIPLE PREGNANCY;
NOTE;
RISK FACTOR;
TWINS;
UTERINE CERVIX;
HEALTH SERVICE;
KAPLAN MEIER METHOD;
NEWBORN MORBIDITY;
PREVALENCE;
PROPHYLAXIS;
SPONTANEOUS PLACENTAL DELIVERY;
TRANSVAGINAL ECHOGRAPHY;
UTERINE CERVIX DISEASE;
CERVIX UTERI;
FEMALE;
GESTATIONAL AGE;
HUMANS;
HYDROXYPROGESTERONES;
PREGNANCY;
PREGNANCY, MULTIPLE;
PREMATURE BIRTH;
PROGESTERONE;
RESEARCH DESIGN;
RISK FACTORS;
TWINS;
KAPLAN-MEIERS ESTIMATE;
|
EID: 36549050355
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc072564 Document Type: Letter |
Times cited : (1)
|
References (5)
|